BPC-157 and TB-500: Frequency and Timing BPC-157 is typically administered twice daily, morning and evening, to maintain consistent tissue-level concentrations throughout the day
Some peptides may clear the bloodstream in minutes, while others remain active for hours or even days due to extended-release mechanisms or depot injections
Preclinical (animal) data Rodent studies suggest BPC-157 may: Promote blood vessel growth Enhance tendon fibroblast activity Reduce inflammation Protect gastrointestinal tissues However, these findings: Use doses far above any human equivalent Use controlled laboratory injuries Do not predict human efficacy 2
WHO will next work with governments and stakeholders to develop a framework to prioritize access for people who are at the highest health risk
She writes from a non-clinical, educational perspective with the intention to inform and empower, not to diagnose or prescribe
If using these meds, it is even more important